KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.502 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $0.202 $0.94
52 weeks $0.202 $3.70

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Dec 04, 2019 $3.60 $3.80 $3.51 $3.70 24 901
Dec 03, 2019 $3.76 $3.78 $3.51 $3.55 47 584
Dec 02, 2019 $3.97 $3.97 $3.59 $3.67 43 024
Nov 29, 2019 $3.58 $3.78 $3.56 $3.77 64 518
Nov 27, 2019 $3.41 $3.60 $3.31 $3.57 60 794
Nov 26, 2019 $3.41 $3.42 $3.34 $3.37 37 718
Nov 25, 2019 $3.32 $3.44 $3.32 $3.38 68 243
Nov 22, 2019 $3.00 $3.35 $2.91 $3.33 109 395
Nov 21, 2019 $3.17 $3.21 $2.94 $2.96 52 017
Nov 20, 2019 $3.35 $3.39 $2.95 $3.17 162 359
Nov 19, 2019 $3.13 $3.41 $3.13 $3.36 29 175
Nov 18, 2019 $2.99 $3.13 $2.98 $3.11 125 153
Nov 15, 2019 $3.00 $3.03 $2.92 $2.99 104 642
Nov 14, 2019 $3.38 $3.40 $2.98 $3.02 71 569
Nov 13, 2019 $3.36 $3.41 $3.28 $3.33 20 114
Nov 12, 2019 $3.35 $3.60 $3.31 $3.35 54 287
Nov 11, 2019 $3.40 $3.52 $3.35 $3.35 25 653
Nov 08, 2019 $3.50 $3.65 $3.34 $3.37 56 052
Nov 07, 2019 $3.49 $3.57 $3.46 $3.54 33 937
Nov 06, 2019 $3.35 $3.48 $3.35 $3.44 17 729
Nov 05, 2019 $3.33 $3.45 $3.27 $3.37 26 031
Nov 04, 2019 $3.52 $3.62 $3.43 $3.44 23 746
Nov 01, 2019 $3.34 $3.60 $3.34 $3.49 42 694
Oct 31, 2019 $3.18 $3.45 $3.10 $3.44 69 176
Oct 30, 2019 $3.28 $3.33 $3.11 $3.22 50 346
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT